Emerging treatments for bacillus Calmette–Guérin-unresponsive non-muscle-invasive bladder cancer

Intravesical bacillus Calmette–Guérin (BCG) immunotherapy has been the gold standard adjuvant treatment for intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) after transurethral resection of bladder tumor (TURBT). BCG immunotherapy prevents disease recurrence and progression to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyung Suk, Seo, Ho Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246016/
https://www.ncbi.nlm.nih.gov/pubmed/34085791
http://dx.doi.org/10.4111/icu.20200602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246016/
https://www.ncbi.nlm.nih.gov/pubmed/34085791
http://dx.doi.org/10.4111/icu.20200602

Ejemplares similares